Miranda Fong
- Cancer Research top 2%
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 3
- Molecular Biology top 5%
- Extracellular vesicles in disease 3
- Immunology top 10%
- Oncology top 10%
- PARP inhibition in cancer therapy 3
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Antiplatelet Therapy and Cardiovascular Diseases 3
-
- Adenosine and Purinergic Signaling 3
- Co-authors
- Sham S. KakarShizhen Emily WangAndrew R. ChinXiwei WuGeorge SomloJonathan E. McDunnJun WuPiotr Swiderski
- Partner nations
- United StatesSpainChina
In The Last Decade
Miranda Fong
36 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Cancer Research 859
- Tourism, Leisure and Hospitality Management 33
- Molecular Biology 1.4k
- Immunology 271
- Oncology 315
Countries citing papers authored by Miranda Fong
This map shows the geographic impact of Miranda Fong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miranda Fong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miranda Fong more than expected).
Fields of papers citing papers by Miranda Fong
This network shows the impact of papers produced by Miranda Fong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miranda Fong. The network helps show where Miranda Fong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Miranda Fong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 25 | |
| 2 | 2018 | 58 | |
| 3 | 2014 | 55 | |
| 4 | 2013 | 3 | |
| 5 | 2012 | 8 | |
| 6 | 2011 | 136 | |
| 7 | 2011 | 65 | |
| 8 | 2009 | 41 | |
| 9 | Abstract 432: Hypervolemic Hyponatremia Aggravates Myocardial Ischemia/Reperfusion Injury: Normalization with Tolvaptan | 2006 | 1 |
| 10 | 2005 | 10 | |
| 11 | 2004 | 16 | |
| 12 | 2002 | 57 | |
| 13 | 2001 | 28 | |
| 14 | 1999 | 90 | |
| 15 | 1997 | 9 | |
| 16 | 1994 | 15 | |
| 17 | 1993 | 21 | |
| 18 | 1993 | 66 | |
| 19 | 1992 | 8 | |
| 20 | 1987 | 5 |
About Miranda Fong
Miranda Fong is a scholar working on Tourism, Leisure and Hospitality Management, Physiology and Cancer Research, having authored 36 papers that have together received 2.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), PARP inhibition in cancer therapy (3 papers), Extracellular vesicles in disease (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Adenosine and Purinergic Signaling (3 papers). The work is most often cited by research in Cancer Research (859 citations), Tourism, Leisure and Hospitality Management (33 citations) and Molecular Biology (1.4k citations). Miranda Fong has collaborated with scholars based in United States, Spain and China. Frequent co-authors include Sham S. Kakar, Shizhen Emily Wang, Andrew R. Chin, Xiwei Wu, George Somlo, Jonathan E. McDunn, Jun Wu, Piotr Swiderski, Weiying Zhou and Xiubao Ren. Their work appears in journals such as Circulation, Nature Communications and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.